These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7334461)

  • 1. The pharmacokinetics of penicillamine in a female mongrel dog.
    Bergstrom RF; Kay RD; Wagner JG
    J Pharmacokinet Biopharm; 1981 Oct; 9(5):603-21. PubMed ID: 7334461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillamine kinetics in normal subjects.
    Bergstrom RF; Kay DR; Harkcom TM; Wagner JG
    Clin Pharmacol Ther; 1981 Sep; 30(3):404-13. PubMed ID: 7273605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of D-penicillamine in man.
    Wiesner RH; Dickson ER; Carlson GL; McPhaul LW; Go VL
    J Rheumatol Suppl; 1981; 7():51-5. PubMed ID: 6939886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of D-penicillamine in a patient with gastrointestinal progressive systemic sclerosis.
    Hendel L; Ammitzbøll T; Kreuzig F; Asboe-Hansen G; Worning H
    Scand J Rheumatol; 1986; 15(1):91-4. PubMed ID: 3961435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inequality of clearance values obtained by intravenous bolus and by steady-state infusion. Prednisolone studies in dogs.
    Frey FJ; Frey BM
    Pharmacology; 1982; 24(6):346-54. PubMed ID: 7111375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
    Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
    Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the infusion of alfentanil in man.
    Fragen RJ; Booij LH; Braak GJ; Vree TB; Heykants J; Crul JF
    Br J Anaesth; 1983 Nov; 55(11):1077-81. PubMed ID: 6416281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of 8-methoxypsoralen in the dog.
    Monbaliu JG; Belpaire FM; Braeckman RA; Bogaert MG
    Biopharm Drug Dispos; 1988; 9(1):9-17. PubMed ID: 3342288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics and metabolism of D- and L-penicillamine. 1. Blood level, transport and protein binding].
    Ruiz-Torres A
    Arzneimittelforschung; 1974 Jun; 24(6):914-7. PubMed ID: 4408088
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonlinear oral pharmacokinetics of the alpha-antagonist 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-[4-(morpholinocarbonyl)-perhydro-1,4-diazepin-1-yl]quinoline in humans: use of preclinical data to rationalize clinical observations.
    Harrison A; Betts A; Fenner K; Beaumont K; Edgington A; Roffey S; Davis J; Comby P; Morgan P
    Drug Metab Dispos; 2004 Feb; 32(2):197-204. PubMed ID: 14744941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and relative bioavailability of D-penicillamine in fasted and nonfasted dogs.
    Langlois DK; Lehner AF; Buchweitz JP; Ross DE; Johnson MB; Kruger JM; Bailie MB; Hauptman JG; Schall WD
    J Vet Intern Med; 2013; 27(5):1071-6. PubMed ID: 23875792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic studies on 14 C-labelled penicillamine].
    Planas-Bohne F
    Arzneimittelforschung; 1972 Sep; 22(9):1426-33. PubMed ID: 4678603
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of recombinant leukocyte A interferon following various routes and modes of administration to the dog.
    Gibson DM; Cotler S; Spiegel HE; Colburn WA
    J Interferon Res; 1985; 5(3):403-8. PubMed ID: 4056487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of metapramine (19560 RP) in man after infusion and intravenous injection.
    Sumirtapura YC; Leroux Y; Komar AR; Cano JP; Gaillot J
    Eur J Clin Pharmacol; 1983; 25(5):673-7. PubMed ID: 6662165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography/tandem mass spectrometric analysis of penicillamine for its pharmacokinetic evaluation in dogs.
    Lehner AF; Dirikolu L; Johnson M; Buchweitz JP; Langlois DK
    Toxicol Mech Methods; 2020 Nov; 30(9):687-702. PubMed ID: 32854553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species.
    Monbaliu J; Verhaeghe T; Willems B; Bode W; Lavrijsen K; Meuldermans W
    Arzneimittelforschung; 2003; 53(7):486-95. PubMed ID: 12918214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of steady-state verapamil plasma concentrations in children and adults.
    Wagner JG; Rocchini AP; Vasiliades J
    Clin Pharmacol Ther; 1982 Aug; 32(2):172-81. PubMed ID: 7094504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-penicillamine metabolism: the role of transformation in blood plasma.
    Joyce DA; Murphy BR
    Agents Actions; 1990 Nov; 31(3-4):353-7. PubMed ID: 2085148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.